CNBX PHARMACEUTICALS INC. (CNBX) Operating income 2016–2025
CNBX PHARMACEUTICALS INC. (CNBX) annual operating income history from SEC filings — each fiscal year as reported.
-$271,691FY2025 · since FY2016: -$280,677 → -$271,691
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$271,691 | +53.4% |
| FY2024 | -$583,139 | +37.4% |
| FY2023 | -$931,380 | +68.5% |
| FY2022 | -$3.0M | -13.6% |
| FY2021 | -$2.6M | +14.6% |
| FY2020 | -$3.0M | +7.9% |
| FY2019 | -$3.3M | +13.3% |
| FY2018 | -$3.8M | -105.4% |
| FY2017 | -$1.9M | -560.5% |
| FY2016 | -$280,677 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CNBX financial trends
CNBX RevenueCNBX Net incomeCNBX Net marginCNBX Gross profitCNBX Gross marginCNBX Operating marginCNBX Operating cash flowCNBX Free cash flowCNBX Capital expendituresCNBX Return on equityCNBX Stock buybacksCNBX Dividends paidCNBX Total assetsCNBX Total liabilitiesCNBX Shareholders’ equityCNBX overview →